SEARCH

SEARCH BY CITATION

References

  • Agostoni C, Zuccotti GV, Giovannini M et al. (1998) Growth in the first two years of uninfected children born to HIV-1 seropositive mothers. Archives of Disease in Childhood 79, 175178.
  • Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P & St Louis ME (1999) Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. International Journal of Epidemiology 28, 532540.
  • Bobat R, Coovadia H, Moodley D, Coutsoudis A & Gouws E (2001) Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa. Annals of Tropical Paediatrics 21, 203210.
  • Breastfeeding and HIV International Transmission Study Group (2004) Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. Journal of Infectious Diseases 189, 21542166.
  • Chisenga M, Kasonka L, Makasa M et al. (2005) Factors affecting the duration of exclusive breastfeeding among HIV-infected and uninfected women in Lusaka, Zambia. Journal of Human Lactation 21, 266275.
  • Chougnet C, Kovacs A, Baker R et al. (2000) Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. Journal of Infectious Diseases 181, 15901597.
  • Clerici M, Saresella M, Colombo F et al. (2000) T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 96, 38663871.
  • Cole TJ, Freeman JV & Preece MA (1998) British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Statistics in Medicine 17, 407429.
  • Coutsoudis A, Pillay K, Spooner E, Coovadia HM, Pembrey L & Newell ML (2005) Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa. South African Medical Journal 95, 339345.
  • European Collaborative Study (2003) Height, weight and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics 111, e52e60.
  • Fawzi WW, Msamanga GI, Spiegelman D et al. (2004) A randomized trial of multivitamin supplements and HIV disease progression and mortality. The New England Journal of Medicine 351, 2332.
  • Filteau SM, Rice AM, Ball JJ et al. (1999) Breast milk immune factors in Bangladeshi women supplemented postpartum with retinol or β-carotene. The American Journal of Clinical Nutrition 69, 953958.
  • Fylkesnes K, Musonda RM, Sichone M, Ndhlovu Z, Tembo F & Monze M (2001) Declining HIV prevalence and risk behaviours in Zambia: evidence from surveillance and population-based surveys. AIDS 15, 907916.
  • Gitau R, Makasa M, Kasonka L et al. (2005) Maternal micronutrient status and decreased growth of Zambian infants born during and after the maize price increases resulting from the Southern African drought of 2001–2002. Public Health Nutrition 8, 837843.
  • Jackson JB, Musoke P, Fleming T et al. (2003) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 362, 859868.
  • John GC, Nduati RW, Mbori-Ngacha DA et al. (2001) Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. Journal of Infectious Diseases 183, 206212.
  • Kasonka L, Makasa M, Marshall T et al. (2006) Risk factors for subclinical mastitis among HIV-infected and uninfected women in Lusaka, Zambia. Pediatric and Perinatal Epidemiology 20, 379391
  • Kuhn L, Kasonde P, Sinkala M et al. (2005) Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clinical Infectious Diseases 41, 16541661.
  • Lepage P, Msellati P, Hitimana DG et al. (1996) Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda 1988 to 1993. The Pediatric Infectious Disease Journal 15, 479485.
  • Miller TL, Easley KA, Zhang W et al. (2001) Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective P2C2 human immunodeficiency virus multicentre study. Pediatrics 108, 12871296.
  • Nakiyingi JS, Bracher M, Whitworth JAG et al. (2003) Child survival in relation to mother's HIV unfection and survival: evidence from a Ugandan cohort study. AIDS 17, 18271834.
  • Newell ML, Brahmbhatt H & Ghys PD (2004a) Child mortality and HIV infection in Africa: a review. AIDS 18, S27S34.
  • Newell ML, Coovadia H, Cortina-Borja M, Rollins N et al. (2004b) Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364, 12361243.
  • Ng'weshemi J, Urassa M, Isingo R et al. (2003) HIV impact on mother and child mortality in rural Tanzania. Journal of Acquired Immune Deficiency Syndromes 33, 393404.
  • Nielsen SD, Jeppesen DL, Kolte L et al. (2001) Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 98, 398404.
  • Ota MOC, O'Donovan D, Marchant A et al. (1999) HIV-negative infants born to HIV-1 but not HIV-2 positive mothers fail to develop a Bacillus Calmette–Guerin scar. AIDS 13, 996998.
  • Phiri W, Kasonka L, Collin S et al. (2006) Factors influencing breast milk HIV RNA viral load among Zambian women. AIDS Research and Human Retroviruses 22, 607614.
  • Shuster DE, Kehrli ME & Baumrucker CR (1995) Relationship of inflammatory cytokines, growth hormone, and insulin-like growth factor-1 to reduced performance during infectious disease. Proceedings of the Society for Experimental Biology and Medicine 10, 140149.
  • Stringer EM, Sinkala M, Stringer JSA et al. (2003) Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling up a nevirapine-based program in Lusaka, Zambia. AIDS 17, 13771382.
  • Thea DM, St Louis ME, Atido U et al. (1993) A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. The New England Journal of Medicine 329, 16961702.
  • WHO (2001) The Optimal Duration of Exclusive Breastfeeding. World Health Organization, Geneva.
  • WHO (2004) Investing in a Comprehensive Health Sector Response to HIV/AIDS: Scaling Up Treatment and Accelerating Prevention. World Health Organization, Geneva, http://www.who.int/3by5/en/HIV_AIDSplan.pdf (accessed May 2006).